SNGL fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Synairgen Plc is a holding company, which engages in the provision of respiratory drug discovery and development. It focuses on severe asthma, chronic obstructive pulmonary disease, and severe viral infections. The company was founded by Donna E. Davies, Ratko Djukanovic, and Stephen T. Holgate in June 2003 and is headquartered in Southampton, the United Kingdom.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
SNGL does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company